{"transactions":[{"id":3539971,"issuer":{"id":7770,"kind":"organization","name":"Medicus Pharma Ltd.","symbol":"MDCX"},"owners":[{"id":41406,"kind":"person","name":"Smith Andrew Alasdair","position":1,"cik":"0001309614","reported_name":"Smith Andrew Alasdair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-08T21:02:20.000Z","date":"2026-09-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on September 4, 2026. The option is scheduled to vest quarterly in four equal installments over one year."}],"balance_after":125000,"derivative":{"exercise_price":0.1705,"expiration_date":"2031-09-04","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950142-26-002522","document":"es260826903_4-smitha.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1997296/000095014226002522/es260826903_4-smitha.xml","form_type":"4"}},{"id":3539970,"issuer":{"id":7770,"kind":"organization","name":"Medicus Pharma Ltd.","symbol":"MDCX"},"owners":[{"id":41406,"kind":"person","name":"Smith Andrew Alasdair","position":1,"cik":"0001309614","reported_name":"Smith Andrew Alasdair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares, no par value","published_at":"2026-09-08T21:02:20.000Z","date":"2026-09-04","kind":"grant","planned":false,"acquired":true,"shares":735294,"price":0.1705,"value":125367.627,"ownership":{"direct":true},"balance_after":735458,"source":{"system":"sec-edgar","filing":"0000950142-26-002522","document":"es260826903_4-smitha.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997296/000095014226002522/es260826903_4-smitha.xml","form_type":"4"}},{"id":749846,"issuer":{"id":7770,"kind":"organization","name":"Medicus Pharma Ltd.","symbol":"MDCX"},"owners":[{"id":41406,"kind":"person","name":"Smith Andrew Alasdair","position":1,"cik":"0001309614","reported_name":"Smith Andrew Alasdair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T20:19:53.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year."}],"balance_after":200000,"derivative":{"exercise_price":0.36,"expiration_date":"2031-06-03","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950142-26-001643","document":"es260786895_4-smitha.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997296/000095014226001643/es260786895_4-smitha.xml","form_type":"4"}},{"id":823091,"issuer":{"id":7770,"kind":"organization","name":"Medicus Pharma Ltd.","symbol":"MDCX"},"owners":[{"id":41406,"kind":"person","name":"Smith Andrew Alasdair","position":1,"cik":"0001309614","reported_name":"Smith Andrew Alasdair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-01T23:22:43.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":0.5,"exercise_date":"2027-03-26","expiration_date":"2031-03-27","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950142-26-001033","document":"es260758781_4-smitha.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997296/000095014226001033/es260758781_4-smitha.xml","form_type":"4"}},{"id":963327,"issuer":{"id":7770,"kind":"organization","name":"Medicus Pharma Ltd.","symbol":"MDCX"},"owners":[{"id":41406,"kind":"person","name":"Smith Andrew Alasdair","position":1,"cik":"0001309614","reported_name":"Smith Andrew Alasdair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-18T21:10:07.000Z","date":"2025-12-16","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year."}],"balance_after":50000,"derivative":{"exercise_price":1.8,"expiration_date":"2030-12-16","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950142-25-003241","document":"es250717288_4-smitha.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997296/000095014225003241/es250717288_4-smitha.xml","form_type":"4"}}]}